US Stocks: Premarket Movers

Upside: -WYY +45% (selected as the single awardee for 10-yr, $3.1B DHS Cellular Wireless Managed Services 3.0 IDIQ contract) -TECH +19% (offered to be acquired by Merck KGaA at $73/shr in $11.3B cash deal) -MU +17% (earnings, guidance) -SNDK +15% (higher in sympathy with MU) -WDC +12% (higher in sympathy with MU) -KYMR +10% (completes enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with topline data by year-end 2026) -QCOM +10% (strength following Investor Day, guidance) -SNX +8.4% (earnings, guidance) -WEN +7.1% (meme momentum) -BB +7.0% (earnings, guidance) -UMAC +4.8% (signs lease for 14K sq ft Orlando manufacturing and operations facility) -STM +4.0% (higher in sympathy with MU) -MKC +3.0% (earnings, guidance) -MDA +2.8% (selected by Mitsubishi Electric for next gen defence communications satellite program) -IBM +2.7% (unveils sub-1 nm chip technology with 0.7 nm node and new nanostack architecture) -VC +2.4% (authorizes $800M share repurchase program) -SPCX +2.3% (momentum) Downside: -ELME -28% (terminates Purchase Agreement with Riverside Apartments) -SPRY -25% (no new formulary additions for neffy in July 1, 2026 cycle) -FUL -10% (earnings, guidance; Ancora criticizes H.B. Fuller pursuit of Advanced Medical Solutions acquisition) -TSHA -5.6% (prices $200M public offering of common stock and pre-funded warrants at $6.00/share) -WGO -3.0% (earnings, guidance) -DLTR -2.8% (to repurchase $500M of common stock alongside secondary block trade) -DRI -2.6% (earnings, guidance) -PVH -2.4% (Tier1 firm Cuts PVH to Underperform from Neutral, price target: $70 from $90)